微生物群
肠道微生物群
生物
因果关系(物理学)
机制(生物学)
肠道菌群
粪便细菌疗法
人口
计算生物学
生物信息学
免疫学
医学
遗传学
物理
认识论
哲学
环境卫生
抗生素
量子力学
艰难梭菌
作者
Zheng Wang,Debby P. Y. Koonen,Marten H. Hofker,Jingyuan Fu
出处
期刊:Current Opinion in Lipidology
[Ovid Technologies (Wolters Kluwer)]
日期:2016-06-01
卷期号:27 (3): 216-224
被引量:69
标识
DOI:10.1097/mol.0000000000000308
摘要
The gut microbiome has now been convincingly linked to human metabolic health but the underlying causality and mechanisms remain poorly understood. This review focuses on the recent progress in establishing the associations between gut microbiome species and lipid metabolism in humans and discusses how to move from association toward causality and mechanistic understanding, which is essential knowledge to bring the observed associations into clinical use.Recent population-based association studies have shown that the gut microbiota composition can explain a substantial proportion of the interindividual variation in blood triglycerides and HDL-cholesterol level and predict metabolic response to diet and drug. Faecal transplantation has suggested that this is a causal effect of microbiome on host metabolism, although the underlying mechanism remains largely unexplored.The gut microbiome is transitioning from being a 'missing' organ to a potential target for therapeutic applications. Due to the complex interplay between the gut microbiome, the host genome, and diet, a systematic approach is required to pave the way for therapeutic development.
科研通智能强力驱动
Strongly Powered by AbleSci AI